Related Experiment Videos
Argon laser treatment of cutaneous vascular lesions in connective tissue diseases
H Zachariae1, P Bjerring, M Cramers
1Department of Dermatology, Marselisborg Hospital, University of Aarhus, Denmark.
Abstract:
Two patients with juvenile dermatomyositis, 5 with chronic discoid lupus erythematosus, and one with Rothmund-Thomson's Syndrome were treated for their teleangiectasias of the face with argon laser. The results were highly satisfactory with an almost normal appearance of treated skin in 4 patients. Two patients showed satisfactory results with 60-70% blanching, while 2 patients showed some improvement, but not a completely cosmetically satisfactory result. The most impressive results were in the patients with juvenile dermatomyositis and Rothmund-Thomson's Syndrome. The only side effects observed were a slight scarring and an insignificant pigmentation. No patient displayed any signs of disease activation.
Insights
Argon laser treatment effectively reduced facial telangiectasias in patients with juvenile dermatomyositis, lupus erythematosus, and Rothmund-Thomson
Area of Science:
- Dermatology
- Laser Therapy
- Medical Treatments
Background:
- Facial telangiectasias are a common cosmetic concern.
- Various conditions like juvenile dermatomyositis and lupus erythematosus can cause facial telangiectasias.
- Effective treatment options are sought for improving cosmetic outcomes.
Observation:
- Eight patients with facial telangiectasias were treated using argon laser therapy.
- Patients had diagnoses including juvenile dermatomyositis, chronic discoid lupus erythematosus, and Rothmund-Thomson's Syndrome.
- Treatment outcomes and side effects were monitored.
Findings:
- Argon laser treatment yielded highly satisfactory results in 4 patients, achieving near-normal skin appearance.
- Two patients experienced 60-70% blanching, while two others showed partial improvement.
- The most significant improvements were observed in patients with juvenile dermatomyositis and Rothmund-Thomson's Syndrome.
- Minor side effects included slight scarring and insignificant pigmentation; no disease activation occurred.
Implications:
- Argon laser therapy is a promising treatment for facial telangiectasias associated with specific dermatological conditions.
- The treatment offers good to excellent cosmetic results with minimal adverse effects.
- Further research may explore optimizing argon laser parameters for diverse patient populations and conditions.